Master protocols helped accelerate research during the pandemic in the EU. How can US companies learn from this and start preparing master protocols now?
Craig Lipset
Advertisement
Advisor and Founder, Clinical Innovation Partners
Articles by Craig Lipset
How management of trials must evolve.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
4
How AI Is Changing Endpoint Selection Before a Trial Even Starts
5